← Back to Screener
Absci Corporation Common Stock (ABSI)
Price$6.40
Value ScoreF
Growth ScoreF
Momentum ScoreA
Favorite Metrics
Price vs S&P 500 (26W)93.97%
Price vs S&P 500 (4W)8.48%
VGM Score36.48
Market Capitalization$997.79M
All Metrics
Book Value / Share (Quarterly)$1.11
P/TBV (Annual)3.55x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-21.33%
Cash Flow / Share (Quarterly)$-0.63
Price vs S&P 500 (YTD)75.22%
Net Profit Margin (TTM)-6450.76%
EPS (TTM)$-0.83
10-Day Avg Trading Volume5.33M
EPS Excl Extra (TTM)$-0.83
Revenue Growth (5Y)-10.14%
EPS (Annual)$-0.84
ROI (Annual)-60.52%
Net Profit Margin (5Y Avg)-2451.57%
Cash / Share (Quarterly)$0.81
Revenue Growth QoQ (YoY)-81.76%
ROA (Last FY)-53.25%
Revenue Growth TTM (YoY)-61.87%
EBITD / Share (TTM)$-0.78
ROE (5Y Avg)-49.39%
Operating Margin (TTM)-6722.98%
Cash Flow / Share (Annual)$-0.62
P/B Ratio5.80x
P/B Ratio (Quarterly)2.71x
Net Income / Employee (Annual)$-822,700
EV / Revenue (TTM)538.99x
Net Interest Coverage (TTM)-549.78x
ROA (TTM)-54.66%
EPS Incl Extra (Annual)$-0.84
Current Ratio (Annual)6.57x
Quick Ratio (Quarterly)6.28x
3-Month Avg Trading Volume4.27M
52-Week Price Return125.35%
Revenue / Employee (TTM)$13,100
Tangible BV / Share (Quarterly)$0.84
P/S Ratio (Annual)356.35x
Asset Turnover (Annual)0.01x
52-Week High$7.39
Operating Margin (5Y Avg)-2431.34%
EPS Excl Extra (Annual)$-0.84
CapEx CAGR (5Y)-12.68%
26-Week Price Return101.89%
Quick Ratio (Annual)6.34x
13-Week Price Return147.10%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)6.59x
Enterprise Value$989.58M
Revenue / Share Growth (5Y)-17.27%
Asset Turnover (TTM)0.01x
Revenue / Employee (Annual)$20,000
Pretax Margin (Annual)-4111.21%
Cash / Share (Annual)$0.95
3-Month Return Std Dev115.61%
Net Income / Employee (TTM)$-846,000
ROE (Last FY)-60.80%
Net Interest Coverage (Annual)-798.63x
EPS Basic Excl Extra (Annual)$-0.84
Receivables Turnover (TTM)13.74x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.83
Receivables Turnover (Annual)3.86x
ROI (TTM)-63.17%
P/S Ratio (TTM)543.46x
Pretax Margin (5Y Avg)-2489.30%
Revenue / Share (Annual)$0.02
Tangible BV / Share (Annual)$0.98
Price vs S&P 500 (52W)100.99%
Year-to-Date Return83.38%
5-Day Price Return-1.84%
EPS Normalized (Annual)$-0.84
ROA (5Y Avg)-41.75%
Net Profit Margin (Annual)-4113.68%
Month-to-Date Return-5.19%
Cash Flow / Share (TTM)$-1.01
EBITD / Share (Annual)$-0.79
Operating Margin (Annual)-4297.04%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-47.98%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-0.83
P/TBV (Quarterly)3.55x
P/B Ratio (Annual)2.77x
Pretax Margin (TTM)-6445.81%
Book Value / Share (Annual)$1.25
Price vs S&P 500 (13W)138.85%
Beta2.46x
Revenue / Share (TTM)$0.01
ROE (TTM)-63.58%
52-Week Low$2.24
vGradeF
gGradeF
mGradeA
vgmGradeD
Show chart for
Earnings Surprise History
Q1 26-0.19est. -0.21
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
4.07
4.07
4.07
4.13
Industry Peers — R&D — Physical Sciences(15)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ABSIAbsci Corporation Common Stock | F | F | A | $6.40 |
| IQVIQVIA Holdings Inc. | C | B | C | $183.45 |
| INCYIncyte Genomics Inc | C | A | B | $102.38 |
| MEDPMedpace Holdings, Inc. Common Stock | D | A | B | $454.25 |
| ICLRIcon Plc | C | C | B | $149.45 |
| CRLCharles River Laboratories International, Inc. | D | D | B | $181.34 |
| NRCNRC Health Common Stock | D | D | B | $19.14 |
| OABIOmniAb, Inc. Common Stock | D | C | A | $2.48 |
| MXCTMaxCyte, Inc. Common Stock | C | D | C | $1.14 |
| ONMDOneMedNet Corp Class A Common Stock | D | C | B | $0.68 |
| BIAFbioAffinity Technologies, Inc. Common Stock | C | F | B | $1.73 |
About
Absci Corp is an AI-powered synthetic biology company focused on developing novel protein therapeutics. Its integrated platform unifies biologic drug discovery and cell line development, enabling faster creation of next-generation biologics.